Urgent revascularization with PCI was more cost-effective than CABG in medically refractory, high-risk myocardial ischemia

摘要

The optimal use of revascularization remains a challenging clinical decision.nThe AWESOME trial by Stroupe and colleagues is indicative of angradually shifting paradigm in which PCI is supplanting CABG acrossnmany subsets of patients.